Latest Articles

Publication Date
NICE recommends treatment for primary advanced or recurrent endometrial cancer - Pf Media

NICE recommends treatment for primary advanced or recurrent endometrial cancer Pf Media

Published: Nov. 26, 2025, 4:10 p.m.
Endometriosis Treatment Market Size, Share & Growth Report by 2034 - Straits Research

Endometriosis Treatment Market Size, Share & Growth Report by 2034 Straits Research

Published: Nov. 26, 2025, 11:31 a.m.
Personalized Vaginal Drug Delivery through 3D Printing: Techniques, Challenges, and Future Perspectives.

Vaginal disorders in reproductive‑age women, including bacterial vaginosis (affecting 23-29%), endometriosis, etc., are increasing alarmingly day by day worldwide. Vaginal drug delivery (VDD) has garnered notable attention in the pharmaceutical …

Published: Nov. 26, 2025, midnight
Appendiceal endometriosis: an uncommon manifestation of deep infiltrating endometriosis.

Appendiceal endometriosis is a rare cause of acute appendicitis, accounting for approximately 1% of cases.This report describes a case of a female patient presenting with right iliac fossa pain and …

Published: Nov. 26, 2025, midnight
Additional treatment option for endometriosis now available - New Zealand Doctor

Additional treatment option for endometriosis now available New Zealand Doctor

Published: Nov. 25, 2025, 11:37 a.m.
Demand for Endometriosis Treatment in Japan | Global Market Analysis Report - 2035 - Future Market Insights

Demand for Endometriosis Treatment in Japan | Global Market Analysis Report - 2035 Future Market Insights

Published: Nov. 24, 2025, 8:01 a.m.
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.

Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive gynecologic malignancy that has only been recognized in the last decade. It arises in the endometrium, ovaries, and other extrauterine sites (often …

Published: Nov. 24, 2025, midnight
Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis.

[This corrects the article DOI: 10.3389/fimmu.2021.641206.].

Published: Nov. 24, 2025, midnight
The Effects of Emotional Freedom Technique on Pelvic Pain and Quality of Life in Women Diagnosed with Endometriosis: A Randomized Controlled Trial.

Objective: The primary goal of treatment for endometriosis (EMS), where pelvic pain is the most significant symptom, is the symptom alleviation. Medical treatment is typically employed until menopause or until …

Published: Nov. 21, 2025, midnight
Demand for Endometriosis Treatment in USA | Global Market Analysis Report - 2035 - Future Market Insights

Demand for Endometriosis Treatment in USA | Global Market Analysis Report - 2035 Future Market Insights

Published: Nov. 20, 2025, 10:11 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!